SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage

Cell Reports

Volumn 10, Issue 10, 2015, Pages 1778-1791

  Hendriks, Ivo A ^a   Treffers, Louise W ^a   Verlaan deVries, Matty ^a   Olsen, Jesper V ^b   Vertegaal, Alfred C O ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CHEMICAL COMPOUND; CHROMATIN MODIFIER; E1A ASSOCIATED P300 PROTEIN; MESYLIC ACID METHYL ESTER; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 1; METHYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEASOME; PROTEIN CBP; PROTEIN JARID1B; PROTEIN JARID1C; PROTEIN RNF4; PROTEIN SETDB1; SUMO 2 PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UNCLASSIFIED ENZYME;

ARTICLE; CHROMATIN; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; HOMOLOGOUS RECOMBINATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; SUMOYLATION; UBIQUITINATION; UPREGULATION;

MAMMALIA;

EID: 84925143779     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.02.033     Document Type: Article

References (60)

1. Alabert C., Bianco J.N., Pasero P. Differential regulation of homologous recombination at DNA breaks and replication forks by the Mrc1 branch of the S-phase checkpoint. EMBO J. 2009, 28:1131-1141.
2. Beck C., Robert I., Reina-San-Martin B., Schreiber V., Dantzer F. Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3. Exp. Cell Res. 2014, 329:18-25.
3. Becker J., Barysch S.V., Karaca S., Dittner C., Hsiao H.H., Berriel Diaz M., Herzig S., Urlaub H., Melchior F. Detecting endogenous SUMO targets in mammalian cells and tissues. Nat. Struct. Mol. Biol. 2013, 20:525-531.
4. Begley T.J., Samson L.D. Network responses to DNA damaging agents. DNA Repair (Amst.) 2004, 3:1123-1132.
5. Bernardi R., Pandolfi P.P. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007, 8:1006-1016.
6. Brouwer A.K., Schimmel J., Wiegant J.C., Vertegaal A.C., Tanke H.J., Dirks R.W. Telomeric DNA mediates de novo PML body formation. Mol. Biol. Cell 2009, 20:4804-4815.
7. Bruderer R., Tatham M.H., Plechanovova A., Matic I., Garg A.K., Hay R.T. Purification and identification of endogenous polySUMO conjugates. EMBO Rep. 2011, 12:142-148.
8. Bueno M.T., Richard S. SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Epigenetics 2013, 8:1162-1175.
9. Chi P., Allis C.D., Wang G.G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
10. Choudhary C., Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 2010, 11:427-439.
11. Flotho A., Melchior F. Sumoylation: a regulatory protein modification in health and disease. Annu. Rev. Biochem. 2013, 82:357-385.
12. Fry R.C., Begley T.J., Samson L.D. Genome-wide responses to DNA-damaging agents. Annu. Rev. Microbiol. 2005, 59:357-377.
13. Galanty Y., Belotserkovskaya R., Coates J., Polo S., Miller K.M., Jackson S.P. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 2009, 462:935-939.
14. Galanty Y., Belotserkovskaya R., Coates J., Jackson S.P. RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 2012, 26:1179-1195.
15. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8:947-956.
16. Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A., Snowden A.W., Garcia-Wilson E., Perkins N.D., Hay R.T. P300 transcriptional repression is mediated by SUMO modification. Mol. Cell 2003, 11:1043-1054.
17. Golebiowski F., Matic I., Tatham M.H., Cole C., Yin Y., Nakamura A., Cox J., Barton G.J., Mann M., Hay R.T. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2009, 2:ra24.
18. González-Prieto R., Muñoz-Cabello A.M., Cabello-Lobato M.J., Prado F. Rad51 replication fork recruitment is required for DNA damage tolerance. EMBO J. 2013, 32:1307-1321.
19. Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M., Vertegaal A.C. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat. Struct. Mol. Biol. 2014, 21:927-936.
20. Hickey C.M., Wilson N.R., Hochstrasser M. Function and regulation of SUMO proteases. Nat. Rev. Mol. Cell Biol. 2012, 13:755-766.
21. Hoege C., Pfander B., Moldovan G.L., Pyrowolakis G., Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002, 419:135-141.
22. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss J.F., Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J.Cell Biol. 1999, 147:221-234.
23. Jackson S.P., Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 2013, 49:795-807.
24. Jelinsky S.A., Samson L.D. Global response of Saccharomyces cerevisiae to an alkylating agent. Proc. Natl. Acad. Sci. USA 1999, 96:1486-1491.
25. Johnson E.S. Protein modification by SUMO. Annu. Rev. Biochem. 2004, 73:355-382.
26. Kandoth C., McLellan M.D., Vandin F., Ye K., Niu B., Lu C., Xie M., Zhang Q., McMichael J.F., Wyczalkowski M.A., et al. Mutational landscape and significance across 12 major cancer types. Nature 2013, 502:333-339.
27. Krishnakumar R., Kraus W.L. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol. Cell 2010, 39:736-749.
28. Luo K., Zhang H., Wang L., Yuan J., Lou Z. Sumoylation of MDC1 is important for proper DNA damage response. EMBO J. 2012, 31:3008-3019.
29. Lyst M.J., Nan X., Stancheva I. Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBO J. 2006, 25:5317-5328.
30. Maeda D., Seki M., Onoda F., Branzei D., Kawabe Y., Enomoto T. Ubc9 is required for damage-tolerance and damage-induced interchromosomal homologous recombination in S. cerevisiae. DNA Repair (Amst.) 2004, 3:335-341.
31. Matic I., Schimmel J., Hendriks I.A., van Santen M.A., van de Rijke F., van Dam H., Gnad F., Mann M., Vertegaal A.C. Site-specific identification of SUMO-2 targets in cells reveals an inverted SUMOylation motif and a hydrophobic cluster SUMOylation motif. Mol. Cell 2010, 39:641-652.
32. Messner S., Schuermann D., Altmeyer M., Kassner I., Schmidt D., Schär P., Müller S., Hottiger M.O. Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J. 2009, 23:3978-3989.
33. Messner S., Altmeyer M., Zhao H., Pozivil A., Roschitzki B., Gehrig P., Rutishauser D., Huang D., Caflisch A., Hottiger M.O. PARP1 ADP-ribosylates lysine residues of the core histone tails. Nucleic Acids Res. 2010, 38:6350-6362.
34. Mitra D., Das P.M., Huynh F.C., Jones F.E. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e. J.Biol. Chem. 2011, 286:40531-40535.
35. Morris J.R., Boutell C., Keppler M., Densham R., Weekes D., Alamshah A., Butler L., Galanty Y., Pangon L., Kiuchi T., et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 2009, 462:886-890.
36. Müller S., Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J.Virol. 1999, 73:5137-5143.
37. Neyret-Kahn H., Benhamed M., Ye T., Le Gras S., Cossec J.C., Lapaquette P., Bischof O., Ouspenskaia M., Dasso M., Seeler J., et al. Sumoylation at chromatin governs coordinated repression of a transcriptional program essential for cell growth and proliferation. Genome Res. 2013, 23:1563-1579.
38. Psakhye I., Jentsch S. Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell 2012, 151:807-820.
39. Ramos Y.F., Hestand M.S., Verlaan M., Krabbendam E., Ariyurek Y., van Galen M., van Dam H., van Ommen G.J., den Dunnen J.T., Zantema A., 't Hoen P.A. Genome-wide assessment of differential roles for p300 and CBP in transcription regulation. Nucleic Acids Res. 2010, 38:5396-5408.
40. Roesch A., Mueller A.M., Stempfl T., Moehle C., Landthaler M., Vogt T. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int. J. Cancer 2008, 122:1047-1057.
41. Saitoh H., Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J.Biol. Chem. 2000, 275:6252-6258.
42. Schimmel J., Eifler K., Sigurdsson J.O., Cuijpers S.A., Hendriks I.A., Verlaan-de Vries M., Kelstrup C.D., Francavilla C., Medema R.H., Olsen J.V., Vertegaal A.C. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol. Cell 2014, 53:1053-1066.
43. Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., Pandolfi P.P. The mechanisms of PML-nuclear body formation. Mol. Cell 2006, 24:331-339.
44. Silva A.M., Vitorino R., Domingues M.R., Spickett C.M., Domingues P. Post-translational modifications and mass spectrometry detection. Free Radic. Biol. Med. 2013, 65:925-941.
45. Silver H.R., Nissley J.A., Reed S.H., Hou Y.M., Johnson E.S. A role for SUMO in nucleotide excision repair. DNA Repair (Amst.) 2011, 10:1243-1251.
46. Stelter P., Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003, 425:188-191.
47. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
48. Stuurman N., de Graaf A., Floore A., Josso A., Humbel B., de Jong L., van Driel R. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J.Cell Sci. 1992, 101:773-784.
49. Sun H., Leverson J.D., Hunter T. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J. 2007, 26:4102-4112.
50. Svejstrup J.Q. The interface between transcription and mechanisms maintaining genome integrity. Trends Biochem. Sci. 2010, 35:333-338.
51. Tammsalu T., Matic I., Jaffray E.G., Ibrahim A.F., Tatham M.H., Hay R.T. Proteome-wide identification of SUMO2 modification sites. Sci. Signal. 2014, 7:rs2.
52. Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N., Jaffray E.G., Palvimo J.J., Hay R.T. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 2008, 10:538-546.
53. Ulrich H.D., Walden H. Ubiquitin signalling in DNA replication and repair. Nat. Rev. Mol. Cell Biol. 2010, 11:479-489.
54. Vázquez M.V., Rojas V., Tercero J.A. Multiple pathways cooperate to facilitate DNA replication fork progression through alkylated DNA. DNA Repair (Amst.) 2008, 7:1693-1704.
55. Vertegaal A.C. Uncovering ubiquitin and ubiquitin-like signaling networks. Chem. Rev. 2011, 111:7923-7940.
56. Vyas R., Kumar R., Clermont F., Helfricht A., Kalev P., Sotiropoulou P., Hendriks I.A., Radaelli E., Hochepied T., Blanpain C., et al. RNF4 is required for DNA double-strand break repair invivo. Cell Death Differ. 2013, 20:490-502.
57. Wang Y., Dasso M. SUMOylation and deSUMOylation at a glance. J.Cell Sci. 2009, 122:4249-4252.
58. Xiang Y., Zhu Z., Han G., Ye X., Xu B., Peng Z., Ma Y., Yu Y., Lin H., Chen A.P., Chen C.D. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proc. Natl. Acad. Sci. USA 2007, 104:19226-19231.
59. Yang W., Thompson J.W., Wang Z., Wang L., Sheng H., Foster M.W., Moseley M.A., Paschen W. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. J.Proteome Res. 2012, 11:1108-1117.
60. Yin Y., Seifert A., Chua J.S., Maure J.F., Golebiowski F., Hay R.T. SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 2012, 26:1196-1208.